Suppr超能文献

患者发生慢性移植物抗宿主病时皮肤受累的解剖分布。

The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.

机构信息

Department of Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee; Vanderbilt University School of Medicine, Nashville, Tennessee.

Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.

出版信息

Biol Blood Marrow Transplant. 2019 Feb;25(2):279-286. doi: 10.1016/j.bbmt.2018.09.007. Epub 2018 Sep 13.

Abstract

Little is known about the anatomic distribution of cutaneous chronic graft-versus-host disease (cGVHD). Using data from the cGVHD Consortium Improving Outcomes Assessment Study, we describe the frequency and extent of erythema and superficial and deep sclerosis in 8 anatomic sites in patients with incident disease (ie, new cGVHD diagnosis within 3 months of study entry) receiving systemic therapy. Of 339 patients with incident disease, 182 (54%) had skin involvement. When an extremity was involved, the same type of disease was present contralaterally in 92% of cases, revealing a high level of symmetry. As anticipated, erythema was the most common incident feature; however, sclerotic skin involvement at the time of cGVHD diagnosis was more common than has been suggested by previous studies. Erythema occurred in 155 (85%) and sclerosis in 53 (29%) of the patients with skin involvement (46% and 16%, respectively, of the entire cohort of 339 incident cGVHD cases). Erythema was least common on the lower extremities (n = 71; 39% of patients with skin involvement). Moveable sclerosis was rare on the head, neck, and scalp (n = 4; 2%). Deep sclerosis did not occur in this region, and instead was most likely to occur on the upper extremities (n = 14; 8%) and lower extremities (n = 14; 8%). More than one-half of patients with erythema (n = 107; 58.7%) had diffuse involvement (4 or more of 8 sites involved), compared with less than one-third of those with sclerosis (n = 16; 30.2%).

摘要

关于皮肤慢性移植物抗宿主病(cGVHD)的解剖分布,人们知之甚少。利用 cGVHD 联盟改善结局评估研究的数据,我们描述了 339 例新发疾病(即研究入组后 3 个月内新诊断为 cGVHD)患者中 8 个解剖部位的红斑、浅表和深部硬化的频率和程度,这些患者正在接受系统治疗。在 339 例新发疾病患者中,182 例(54%)存在皮肤受累。当一个肢体受累时,92%的病例对侧出现相同类型的疾病,显示出高度的对称性。正如预期的那样,红斑是最常见的新发特征;然而,在 cGVHD 诊断时存在硬化性皮肤受累比以前的研究表明的更为常见。在有皮肤受累的患者中,155 例(85%)出现红斑,53 例(29%)出现硬化(分别占整个 339 例新发 cGVHD 病例队列的 46%和 16%)。红斑在下肢最不常见(71 例;占皮肤受累患者的 39%)。头部、颈部和头皮的活动性硬化罕见(4 例;2%)。深部硬化不会发生在此区域,而最有可能发生在上肢(14 例;8%)和下肢(14 例;8%)。超过一半的红斑患者(n=107;58.7%)有弥漫性受累(4 个或更多的 8 个部位受累),而硬化的患者不到三分之一(n=16;30.2%)。

相似文献

1
The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2019 Feb;25(2):279-286. doi: 10.1016/j.bbmt.2018.09.007. Epub 2018 Sep 13.
3
Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
Arch Dermatol. 2009 Aug;145(8):918-22. doi: 10.1001/archdermatol.2009.78.
4
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
Br J Dermatol. 2014 Jul;171(1):63-8. doi: 10.1111/bjd.12828. Epub 2014 Jun 24.
6
Oral disease profiles in chronic graft versus host disease.
J Dent Res. 2015 Apr;94(4):547-54. doi: 10.1177/0022034515570942. Epub 2015 Mar 4.
8
Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease.
Am J Dermatopathol. 2024 Nov 1;46(11):755-760. doi: 10.1097/DAD.0000000000002841. Epub 2024 Sep 17.
9
Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
Arch Dermatol Res. 2023 Nov;315(9):2545-2554. doi: 10.1007/s00403-023-02626-1. Epub 2023 May 25.
10
Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
JAMA Dermatol. 2019 Jul 1;155(7):833-837. doi: 10.1001/jamadermatol.2018.5459.

引用本文的文献

2
Non-Expert Markings of Active Chronic Graft-Versus-Host Disease Photographs: Optimal Metrics of Training Effects.
J Digit Imaging. 2023 Feb;36(1):373-378. doi: 10.1007/s10278-022-00730-8. Epub 2022 Nov 7.
3
Baseline Photos and Confident Annotation Improve Automated Detection of Cutaneous Graft-Versus-Host Disease.
Clin Hematol Int. 2021 Jul 15;3(3):108-115. doi: 10.2991/chi.k.210704.001. eCollection 2021 Sep.
4
Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.
Transplant Cell Ther. 2021 Sep;27(9):738-746. doi: 10.1016/j.jtct.2021.05.030. Epub 2021 Jun 6.

本文引用的文献

3
NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.
Bone Marrow Transplant. 2014 Dec;49(12):1513-20. doi: 10.1038/bmt.2014.188. Epub 2014 Aug 25.
4
Assessment of joint and fascia manifestations in chronic graft-versus-host disease.
Arthritis Rheumatol. 2014 Apr;66(4):1044-52. doi: 10.1002/art.38293.
6
Characteristics of chronic GVHD after cord blood transplantation.
Bone Marrow Transplant. 2013 Oct;48(10):1285-90. doi: 10.1038/bmt.2013.48. Epub 2013 Apr 15.
7
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.
Blood. 2013 Jun 20;121(25):5098-103. doi: 10.1182/blood-2012-10-464198. Epub 2013 Apr 1.
9
Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.
Blood. 2012 Sep 27;120(13):2545-52; quiz 2774. doi: 10.1182/blood-2012-04-424135. Epub 2012 Jul 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验